Iocetamic Acid

CHEMBL1200770 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
614.0 g/mol
LogP
2.6
Phase
4

This iodinated compound was used as an oral cholecystographic contrast agent to visualize the gallbladder on X-ray examination. After oral ingestion and intestinal absorption, it is taken up and concentrated in the gallbladder, making it and any gallstones visible on X-ray. This technique has been largely replaced by ultrasound imaging.

आणविक भार

613.9600 g/mol

LogP

2.60

TPSA

83.60 Ų

लिपिंस्की RO5

उत्तीर्ण

क्रिया का तंत्र

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I

InChI

InChI=1S/C12H13I3N2O3/c1-5(12(19)20)4-17(6(2)18)11-8(14)3-7(13)10(16)9(11)15/h3,5H,4,16H2,1-2H3,(H,19,20)

Molecular Formula

C12H13I3N2O3

HBD / HBA

2 / 4

घूर्णनीय बंधन

4

भारी परमाणु

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This iodinated compound was used as an oral cholecystographic contrast agent to visualize the gallbladder on X-ray examination. After oral ingestion and intestinal absorption, it is taken up and concentrated in the gallbladder, making it and any gallstones visible on X-ray. This technique has been largely replaced by ultrasound imaging.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Iocetamic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200770. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 27648. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.